Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors

Veterinary Pathology

Volumn 47, Issue 4, 2010, Pages 643-653

  Sabattini, S ^a   Bettini, Giuliano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cats; Immunohistochemistry; Ki67; KIT; Mast cell tumor; Mitotic index; Prognosis; Telomerase

Indexed keywords

KI 67 ANTIGEN; STEM CELL FACTOR RECEPTOR; TELOMERASE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MASTOCYTOSIS; METABOLISM; MITOSIS INDEX; NONPARAMETRIC TEST; PATHOLOGY; RETROSPECTIVE STUDY; SKIN TUMOR; VETERINARY;

ANIMALS; CAT DISEASES; CATS; FEMALE; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MASTOCYTOSIS; MITOTIC INDEX; PROTO-ONCOGENE PROTEINS C-KIT; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; STATISTICS, NONPARAMETRIC; TELOMERASE;

FELIDAE;

EID: 77954949456     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985810364509     Document Type: Article

References (39)

1. Abadie J.: Mastocitomi canini e felini. Summa Animali da Compagnia 10:41-48, 2006.
2. Bostock DE: Neoplasms of the skin and subcutaneous tissues in dogs and cats. Br Vet J 142:1-19, 1986.
3. Buerger RG, Scott DW: Cutaneous mast cell neoplasia in cats: 14 cases (1975-1985). J Am Vet Med Assoc 190:1440-1444, 1987.
4. Carpenter JL, Andrews LK, Holzworth J.: Tumors and tumor-like lesions. In: Diseases of the Cat, Medicine and Surgery, ed. Holzworth J, pp. 569-579. WB Saunders, Philadelphia, PA, 1987.
5. Chastain CB, Turk MA, O'Brien D.: Benign cutaneous mastocytomas in two litters of Siamese kittens. J Am Vet Med Assoc 193:959-960, 1988.
6. Chaves-Dias C., Hundley TR, Gilfillan AM, Kirshenbaum AS, Cunha-Melo JR, Metcalfe DD, Beaven MA: Induction of telomerase activity during development of human mast cells from peripheral blood CD34+ cells: comparisons with tumor mast-cell lines. J Immunol 166:6647-6656, 2001.
7. Downing S., Chien MB, Kass PH, Moore PE, London CA: Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs. Am J Vet Res 63:1718-1723, 2002.
8. Fusaro L., Panarese S., Brunetti B., Zambelli D., Benazzi C., Sarli G.: Quantitative analysis of telomerase in feline mammary tissues. J Vet Diagn Invest 21:369-373, 2009.
9. Gil da Costa RM, Matos E., Rema A., Lopes C., Pires MA, Gärtner F.: CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers. BMC Vet Res 3:19-25, 2007.
10. Goldschmidt MH, Hendrick MJ: Mast cell tumor. In: Tumors in Domestic Animals, ed. Meuten DJ, 4th ed., p. 107. Iowa State Press, Ames, IA, 2002.
11. Gross TL, Ihrke PJ, Walder EJ, Affolter VK: Skin Diseases of the Dog and Cat, 2nd ed., pp. 858-861. Blackwell Science LTD, Oxford, UK, 2005.
12. Hendrick MJ, Mahaffey EA, Moore FM, Vos JH, Walder EJ: Mast cell tumors. In: World Health Organization International Histological Classification of Tumors of Domestic Animals, Histological Classification of Mesenchymal Tumors of the Skin and Soft Tissues of Domestic Animals, 2nd series, ed. Schulman FY, p. 28. Armed Forces Institute of Pathology, Washington, DC, 1998.
13. Holzinger EA: Feline cutaneous mastocytomas. Cornell Vet 63:87-93, 1973.
14. Isotani M., Tamura K., Yagihara H., Hikosaka M., Ono K., Washizu T., Bonkobara M.: Identification of a c-Kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate. Vet Immunol Immunopathol 114:168-172, 2006.
15. Johnson TO, Schulman FY, Lipscomb TP, Yantis LD: Histopathology and biologic behavior of pleomorphic cutaneous mast cell tumors in fifteen cats. Vet Pathol 39:452-457, 2002.
16. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.
17. Kiupel M., Webster JD, Kaneene JB, Miller R., Yuzbasiyan-Gurkan V.: The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol 41:371- 377, 2004.
18. Lepri E., Ricci G., Leonardi L., Sforna M., Mechelli L.: Diagnostic and prognostic features of feline cutaneous mast cell tumours: a retrospective analysis of 40 cases. Vet Res Commun 27:707- 709, 2003.
19. Litster AL, Sorenmo KU: Characterisation of signalment, clinical and survival characteristics of 41 cats with mast cell neoplasia. J Feline Med Surg 8:177-183, 2006.
20. London CA, Galli SJ, Yuuki T., Hu ZQ, Helfand SC, Geissler EN: Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Exp Hematol 27:689-697, 1999.
21. London CA, Hannah AL, Zadovoskaya R., Chien MB, Kollias-Baker C., Rosenberg M., Downing S., Post G., Boucher J., Shenoy N., Mendel DB, McMahon G., Cherrington JM: Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clin Cancer Res 9:2755-2768, 2003.
22. Macy DW, Reynolds HA: The incidence, characteristics and clinical management of skin tumors in cats. J Am Anim Hosp Assoc 17:1026-1034, 1981.
23. Mandrioli L., Panarese S., Cesari A., Mandara MT, Marcato PS, Bettini G.: Immunohistochemical expression of h-telomerase reverse transcriptase in canine and feline meningiomas. J Vet Sci 8:111-115, 2007.
24. Miettinen M., Lasota J.: Gastrointestinal stromal tumors: clinical, histological, immunohistochemical and molecular genetic features and differential diagnosis. Virchows Arch 438:1-12, 2001.
25. Miller MA, Nelson SL, Turk JR, Pace LW, Brown TP, Shaw DP, Fischer JR, Gosser HS: Cutaneous neoplasia in 340 cats. Vet Pathol 28:389-395, 1991.
26. Molander-McCrary H., Henry CJ, Potter K., Tyler JW, Buss MS: Cutaneous mast cell tumors in cats: 32 cases (1991-1994). J Am Anim Hosp Assoc 34:281-284, 1998.
27. Morini M., Bettini G., Preziosi R., Mandrioli L.: C-kit gene product (CD117) immunoreactivity in canine and feline paraffin sections. J Histochem Cytochem 52:705-708, 2004.
28. Nasir L.: Telomeres and telomerase: biological and clinical importance in dogs. Vet J 175:155-163, 2008.
29. Oligvie GK, Moore AS: Feline Oncology, pp. 407-412. Veterinary Learning System, Trenton, NJ, 2001.
30. Patnaik AK, Ehler WJ, MacEwen EG: Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 21:469-474, 1984.
31. Preziosi R., Morini M., Sarli G.: Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog. J Vet Diagn Invest 16:554-561, 2004.
32. Pulley LT, Stannard AA: Tumors of the skin and soft tissues. In: Tumors of Domestic Animals, ed. Moulton JE, 3rd ed., p. 43. University of California Press, Davis, CA, 1990.
33. Rodriguez-Carino C., Fondevila D., Segales J., Rabanal R.: Expression of KIT receptor in feline cutaneous mast cell tumors. Vet Pathol 46:878-883, 2009.
34. Thamm DH, Vail DM: Mast cell tumors. In: Withrow and MacEwen's Small Animal Clinical Oncology, 4th ed., pp. 416-420. WB Saunders, Philadelphia, PA, 2007.
35. Webster JD, Yuzbasiyan-Gurkan V., Miller RA, Kaneene JB, Kiupel M.: Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication. Vet Pathol 44:298-308, 2007.
36. Wilcock BP, Yager JA, Zink MC: The morphology and behavior of feline cutaneous mastocytomas. Vet Pathol 23:320-324, 1986.
37. Yazawa M., Okuda M., Setoguchi A., Nishimura R., Sasaki N., Hasegawa A., Watari T., Tsujimoto H.: Measurement of telomerase activity in dog tumors. J Vet Med Sci 61:1125-1129, 1999.
38. Zemke D., Yamini B., Yuzbasiyan-Gurkan V.: Characterization of an undifferentiated malignancy as a mast cell tumor using mutation analysis in the proto-oncogene c-kit. J Vet Diagn Invest 13:341-345, 2001.
39. Zemke D., Yamini B., Yuzbasiyan-Gurkan V.: Mutations in the juxtamembrane domain of c-kit are associated with higher grade mast cell tumors in dogs. Vet Pathol 39:529-535, 2002.